Literature DB >> 24806691

Social stress and CRF-dopamine interactions in the VTA: role in long-term escalation of cocaine self-administration.

Christopher O Boyson1, Elizabeth N Holly, Akiko Shimamoto, Lucas Albrechet-Souza, Lindsay A Weiner, Joseph F DeBold, Klaus A Miczek.   

Abstract

The nature of neuroadaptations in the genesis of escalated cocaine taking remains a topic of considerable interest. Intermittent social defeat stress induces both locomotor and dopaminergic cross-sensitization to cocaine, as well as escalated cocaine self-administration. The current study examines the role of corticotropin releasing factor receptor subtypes 1 and 2 (CRFR1, CRFR2) within the ventral tegmental area (VTA) during social defeat stress. This study investigated whether injecting either a CRFR1 or CRFR2 antagonist directly into the VTA before each social defeat would prevent the development of later (1) locomotor sensitization, (2) dopaminergic sensitization, and (3) escalated cocaine self-administration in rats. CRFR1 antagonist CP376395 (50 or 500 ng/side), CRFR2 antagonist Astressin2-B (100 or 1000 ng/side), or vehicle (aCSF) was microinjected into the VTA 20 min before social defeat stress (or handling) on days 1, 4, 7, and 10. Ten days later, rats were injected with cocaine (10 mg/kg, i.p.) and assessed for either locomotor sensitization, measured by walking activity, or dopaminergic sensitization, measured by extracellular dopamine (DA) in the nucleus accumbens shell (NAcSh) through in vivo microdialysis. Locomotor sensitization testing was followed by intravenous cocaine self-administration. Intra-VTA antagonism of CRFR1, but not CRFR2, inhibited the induction of locomotor cross-sensitization to cocaine, whereas both prevented dopaminergic cross-sensitization and escalated cocaine self-administration during a 24 h "binge." This may suggest dissociation between locomotor sensitization and cocaine taking. These data also suggest that interactions between CRF and VTA DA neurons projecting to the NAcSh are essential for the development of dopaminergic cross-sensitization to cocaine.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24806691      PMCID: PMC4012317          DOI: 10.1523/JNEUROSCI.3942-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  56 in total

Review 1.  Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress.

Authors:  Kathleen T Brady; Rajita Sinha
Journal:  Am J Psychiatry       Date:  2005-08       Impact factor: 18.112

2.  A glutamate-dopamine interaction in the persistent enhanced response to amphetamine in nucleus accumbens core but not shell following a single restraint stress.

Authors:  Alejandra M Pacchioni; Martine Cador; Claudia Bregonzio; Liliana M Cancela
Journal:  Neuropsychopharmacology       Date:  2006-04-19       Impact factor: 7.853

3.  Heroin-induced reinstatement is specific to compulsive heroin use and dissociable from heroin reward and sensitization.

Authors:  Magalie Lenoir; Serge H Ahmed
Journal:  Neuropsychopharmacology       Date:  2006-04-26       Impact factor: 7.853

4.  The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress.

Authors:  Brook Henry; Wylie Vale; Athina Markou
Journal:  J Neurosci       Date:  2006-09-06       Impact factor: 6.167

5.  NMDA receptors in the rat VTA: a critical site for social stress to intensify cocaine taking.

Authors:  Herbert E Covington; Thomas F Tropea; Anjali M Rajadhyaksha; Barry E Kosofsky; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2007-12-19       Impact factor: 4.530

6.  Synapses between corticotropin-releasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic.

Authors:  Patricia Tagliaferro; Marisela Morales
Journal:  J Comp Neurol       Date:  2008-02-01       Impact factor: 3.215

7.  CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats.

Authors:  Sheila E Specio; Sunmee Wee; Laura E O'Dell; Benjamin Boutrel; Eric P Zorrilla; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2007-10-30       Impact factor: 4.530

8.  Corticotropin-releasing factor receptors in the dorsal raphe nucleus modulate social behavior in Syrian hamsters.

Authors:  Matthew A Cooper; Kim L Huhman
Journal:  Psychopharmacology (Berl)       Date:  2007-06-21       Impact factor: 4.530

9.  Lack of relation between drug-seeking behavior in an addiction model and the expression of behavioral sensitization in response to ethanol challenge in mice.

Authors:  A F Ribeiro; G Pigatto; F O Goeldner; J F Lopes; R B de Lacerda
Journal:  J Neural Transm (Vienna)       Date:  2007-12-18       Impact factor: 3.575

10.  Stress and CRF gate neural activation of BDNF in the mesolimbic reward pathway.

Authors:  Jessica J Walsh; Allyson K Friedman; Haosheng Sun; Elizabeth A Heller; Stacy M Ku; Barbara Juarez; Veronica L Burnham; Michelle S Mazei-Robison; Deveroux Ferguson; Sam A Golden; Ja Wook Koo; Dipesh Chaudhury; Daniel J Christoffel; Lisa Pomeranz; Jeffrey M Friedman; Scott J Russo; Eric J Nestler; Ming-Hu Han
Journal:  Nat Neurosci       Date:  2013-11-24       Impact factor: 24.884

View more
  37 in total

1.  Susceptibility to traumatic stress sensitizes the dopaminergic response to cocaine and increases motivation for cocaine.

Authors:  Zachary D Brodnik; Emily M Black; Meagan J Clark; Kristen N Kornsey; Nathaniel W Snyder; Rodrigo A España
Journal:  Neuropharmacology       Date:  2017-08-01       Impact factor: 5.250

2.  Diazepam reverses increased anxiety-like behavior, social behavior deficit, and dopamine dysregulation following withdrawal from acute amphetamine.

Authors:  Millie Rincón-Cortés; Kimberly G Gagnon; Hannah K Dollish; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2018-06-18       Impact factor: 7.853

Review 3.  Social Stress-Induced Alterations in CRF Signaling in the VTA Facilitate the Emergence of Addiction-like Behavior.

Authors:  Brendan J Tunstall; Stephanie A Carmack
Journal:  J Neurosci       Date:  2016-08-24       Impact factor: 6.167

Review 4.  Region-specific roles of the corticotropin-releasing factor-urocortin system in stress.

Authors:  Marloes J A G Henckens; Jan M Deussing; Alon Chen
Journal:  Nat Rev Neurosci       Date:  2016-09-02       Impact factor: 34.870

5.  Prevention and reversal of social stress-escalated cocaine self-administration in mice by intra-VTA CRFR1 antagonism.

Authors:  Xiao Han; Joseph F DeBold; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2017-07-11       Impact factor: 4.530

6.  Escalation of cocaine self-administration in adulthood after social defeat of adolescent rats: role of social experience and adaptive coping behavior.

Authors:  Andrew R Burke; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2015-05-07       Impact factor: 4.530

7.  Overexpression of BDNF in the ventral tegmental area enhances binge cocaine self-administration in rats exposed to repeated social defeat.

Authors:  Junshi Wang; Ryan M Bastle; Caroline E Bass; Ronald P Hammer; Janet L Neisewander; Ella M Nikulina
Journal:  Neuropharmacology       Date:  2016-05-03       Impact factor: 5.250

8.  Early adolescent adversity inflates threat estimation in females and promotes alcohol use initiation in both sexes.

Authors:  Rachel A Walker; Christopher Andreansky; Madelyn H Ray; Michael A McDannald
Journal:  Behav Neurosci       Date:  2018-06       Impact factor: 1.912

9.  Escalated cocaine "binges" in rats: enduring effects of social defeat stress or intra-VTA CRF.

Authors:  Michael Z Leonard; Joseph F DeBold; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2017-07-18       Impact factor: 4.530

10.  Social stress-escalated intermittent alcohol drinking: modulation by CRF-R1 in the ventral tegmental area and accumbal dopamine in mice.

Authors:  Lara S Hwa; Elizabeth N Holly; Joseph F DeBold; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2015-11-18       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.